Ge
Non verificato

GenSight Biologics S.A.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieOtticaSalute
18/05/2026
Salute
Medicina - Varie
Farmaceutica
Ottica
Biotecnologia
GenSight Biologics to Hold its Combined General Meeting on May 19, 2026
1.00
11/05/2026
Industria
Libri/Editoria
Biotecnologia
Comunicazione
Medicina - Varie
Salute
Farmaceutica
Ottica
GenSight Biologics Announces Publication on Matching-Adjusted Indirect Comparison of Leber Hereditary Optic Neuropathy Treatments
1.00
28/04/2026
Web e Social Network
Finanza
Salute
Biotecnologia
Farmaceutica
Ottica
GenSight Biologics Announces Annual General Meeting to Take Place on May 19, 2026
1.00
18/02/2026
Salute
Biotecnologia
Sanità
Medicina - Varie
Ottica
Mercato del lavoro
GenSight Biologics Bolsters Regulatory Leadership in US and Europe with Two Senior Appointments
1.00
10/02/2026
Biotecnologia
Farmaceutica
Ottica
Sanità
Salute
Medicina - Varie
Mercato del lavoro
Industria
The 15-20 National Hospital and GenSight Biologics Announce the Treatment of the First Patient in the GS010/LUMEVOQ® REVISE Study
1.00
28/01/2026
Salute
Biotecnologia
Medicina - Varie
Farmaceutica
Ottica
GenSight Biologics Announces the Results of its Extraordinary General Meeting of January 28, 2026
1.00
22/12/2025
Industria
Salute
Biotecnologia
Medicina - Varie
Farmaceutica
Ottica
GenSight Biologics Announces Regulatory Authorization for Early Access Treatment with GS010/LUMEVOQ® in Israel
1.00
28/08/2025
Biotecnologia
Farmaceutica
Salute
Mercato azionario
Finanza
Web e Social Network
Telefonia e Varie
GenSight Biologics Postpones Release of 2025 Half-Year Financial Results
1.00
08/04/2025
Biotecnologia
Salute
Farmaceutica
Ottica
GenSight Biologics Announces the Filing of its 2024 Universal Registration Document
1.00

Recapiti

Social Media

Seguaci
0
Compatibilità
0